All treatments

One number a month.
Everything included.

Provider review, medication if prescribed, shipping, and ongoing support, at one transparent price. Choose a starting point; a provider decides whether it is appropriate for you.

Start your assessment See pricing →

More Affordable

Semaglutide Injections

Once-weekly GLP-1. Brand pathway studied in STEP 1; compounded is not the brand product.

From $166/month

Once weekly · titrated

Get started

Learn more →

Dual-action

Tirzepatide Injections

Once-weekly dual GLP-1/GIP. Brand pathway studied in SURMOUNT; compounded is not the brand product.

From $199/month

Once weekly · titrated

Get started

Learn more →

These medications are compounded by state-licensed 503A pharmacies and are not FDA-approved products. All medications require a valid prescription from a licensed healthcare provider.

Every plan

Everything bundled. Nothing upsold.

US-licensed providers

A provider reviews your history and authorizes your prescription, or declines.

503A compounding

State-licensed pharmacy only. Prepared for your prescription.

Cold-packed shipping

Temperature-controlled expedited shipping when medication is prescribed.

Dose titration

Adjusted as you respond, not a fixed ship-and-forget dose.

24/7 messaging

Provider messaging for active patients.

FSA / HSA eligible

Itemized receipts every month. No membership fees.

Side by side

Which plan fits?

	Semaglutide	Tirzepatide
Format	Weekly injection	Weekly injection
Mechanism	GLP-1	GLP-1 + GIP
Often considered for	Single-pathway GLP-1, lower from-price	Dual GLP-1/GIP pathway
From (3-month plan)	$166/mo	$199/mo
Provider review	Included	Included
Ongoing support	Included	Included

See full pricing

Before you begin

Not for everyone.

GLP-1 therapy isn't appropriate for every patient. A licensed provider screens for these during your assessment, so please share your full history.

Personal/family history of medullary thyroid carcinoma (MTC)

Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Pregnancy, planning pregnancy, or breastfeeding

History of pancreatitis or known allergy to the medication

GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumors observed in rodents; it is unknown whether they cause medullary thyroid carcinoma (MTC) in humans. They are contraindicated in patients with a personal or family history of MTC or MEN 2. These medications are compounded by state-licensed 503A pharmacies and are not FDA-approved finished products. This page is educational and is not medical advice. Eligibility is always determined by a licensed provider after reviewing your full history.

No consultation fee

The consultation carries no charge. You pay only if prescribed.

Start your assessment

30-day money-back guarantee on your first month (see policy)

One number a month.Everything included.